Versant HIV-1 Assay Approval Could Cut Lab Labor In Half – Bayer
This article was originally published in The Gray Sheet
Bayer Diagnostics' Versant HIV-1 RNA 3.0 assay is the first viral load test approved by FDA that can detect any clinically significant change in HIV-1 in one test-run, the company claims
You may also be interested in...
Acquisition of Chiron Diagnostics for $1.1 bil. provides Bayer with an entry into the blood gas analysis market, broadens clinical laboratory systems offerings and will accelerate development efforts in the field of nucleic acid diagnostics.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.